痴情启动和妻子爱相随

来源 :侨园 | 被引量 : 0次 | 上传用户:chenshuae5b
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
2005年6月30日凌晨2点25分,著名书画家、教育家、国学大师,北京师范大学教授启功先生因病在北大医院逝世,享年93岁。奉母命成婚得知己启功先生的全名叫爱新觉罗·启功,但他在所有的书画、著作、文章和书信中,从未用过“爱新觉罗”。他诙谐地说:“本人姓启名功字元白,不吃祖宗饭,不当‘八旗子弟’,靠自己的本领谋生。”启功1912年7月26日生于北京,他的童年非常坎坷。启功的祖先是雍正的儿子,乾隆的弟弟。但是到了启功的高祖父这一代,家道开始没落。启功1岁丧父,10岁时又失去曾祖父、祖父。因偿还债务,以致无力求学。在曾祖父门生戴遂之的帮助下,他才勉强入校学习。开朗乐观的启功明白自己是彻底“被遗弃的贵族后裔”,那何不隐其姓,先解决生计再图发展?于是他自创“启”姓,自当“始祖”。 At 25:25 on June 30, 2005, Mr. Qi Gong, a famous calligrapher, educator, master of Chinese studies and professor at Beijing Normal University, died at the age of 93 at the Peking University Hospital. He is known as Aixinjueluo Qigong because of his marriage to his mother, but he has never used Aixinjueluo in all his paintings, writings, essays and letters. He jokingly said: “My name surnamed Qu Yuan Yuan Bai, do not eat ancestral rice, improper ’Eight Banners’, rely on their own ability to make a living.” Kai Gong July 26, 1912 was born in Beijing, his childhood is very bumpy. The ancestors of Qigong are the son of Emperor Yongzheng and his brother Qianlong. However, to the great grandfather of Kai-kung this generation, family began to decline. One year old Qigong lost his father, 10 years old and lost his great-grandfather, grandfather. Because of debt repayments, unable to learn. With the help of his great-grandfather, Dai Sui-zhi, he barely entered school. Cheerful and optimistic Qigong understand that they are completely “abandoned aristocrats descendants”, then why not hide their surnames, the first solution to livelihood and then development? So he created “Kai” surname, since the “ancestor.”
其他文献
疾病控制中心(CDC)是美国预防医学机构,1992年10月27日改名为疾病控制与预防中心(Centers for Disease Control and Prevention),其缩写仍为CDC.此改名是经国会通过的,以承
通风除尘在防尘工作中是一项积极有效的技术措施,广泛应用于厂矿企业粉尘作业场所。为探讨该技术措施在防尘工作中的实际效果,我们对近年来测试的127个厂矿527套通风除尘系
那时,勤快的东方见组次数之多可以说是破纪录的。在两个月内曾见过六十多个组。记得有一次台湾导演协会会长李行导演等客人来学院参观,当他见到东方时连声说:“形象好!形象好
会议
中国特色政治道德价值观要求立足于最广大人民的根本利益,以实现社会主义和共产主义为理想信念,其实质是坚持以建设全党和全国各族人民团结奋斗的共同思想基础——社会主义核
胃癌是全球最为常见的恶性肿瘤之一,晚期胃癌预后差,一线化疗后复发或疾病进展发生率高,患者生存率低,同时可选择的后线治疗手段有限。三线治疗可使经选定的晚期胃癌患者生存获益。目前,多项化疗、靶向治疗和免疫治疗相关的临床研究及真实世界研究正在开展之中。此外,联合治疗的探索、如何通过寻找临床特征或者生物学标志物筛选最佳的获益人群,也是研究者们关注的热点。文章将详细概述晚期胃癌三线治疗的现状和进展,并深入探
  利用红外光谱结合二阶导数谱对肉苁蓉原药材及其醇提物进行了研究。结果表明:(1)管花肉苁蓉中与松果菊苷和毛蕊花糖苷有关的吸收峰1692,1631,1604,1516,1447,1158,812cm-1
会议
会议